DHHS → node
In September of 2022, the Office of MaineCare Services provided public notice that it initiated a rate determination for Section 60 Medical Supplies and DME prior to P.L. 2021 Ch. 639.
AUGUSTA — The Maine Department of Health and Human Services (DHHS) closed its district office at 200 Main Street in Lewiston today due to water and electrical damage resulting from the extreme cold weather in the past few days. The office is undergoing repairs and will reopen to the public and employees as soon as possible to ensure continued access to critical benefits and services.
As mentioned in the notice on February 2, 2023, the Department now has available the Behavioral Health Rate FAQ document on billing and authorizations for serv
As previously shared in our September 27, 2022 bulletin, the Department initiated a rate determination process for Section 31, Federally Qualified Health Centers, (FQHCs).
Effective January 20, 2023, MaineCare added additional albuterol products with preferred status to our Preferred Drug List (PDL). These preferred products do not require prior authorization (PA):
On December 29, 2022, Congress eliminated the “DATA-Waiver Program” with the signing of the Consolidated Appropriations Act of 2023 (the Act), improving access to buprenorphine for those in need.
On December 29, 2022, Congress eliminated the “DATA-Waiver Program” with the signing of the Consolidated Appropriations Act of 2023 (the Act), improving access to buprenorphine for those in need.
On December 29, 2022, Congress eliminated the “DATA-Waiver Program” with the signing of the Consolidated Appropriations Act of 2023 (the Act), improving access to buprenorphine for those in need.
On December 29, 2022, Congress eliminated the “DATA-Waiver Program” with the signing of the Consolidated Appropriations Act of 2023 (the Act), improving access to buprenorphine for those in need.
As a follow-up to our June 21, 2022 e-message regarding Behavioral Health and Targeted Case Management supplemental payments for providers of: